{
    "clinical_study": {
        "@rank": "135990", 
        "arm_group": {
            "arm_group_label": "Subfertile couples", 
            "description": "Subfertile couples presenting at fertility clinics with an indication for IUI in stimulated cycles\nAll patients will receive a fixed 75 IU recombinant follicle stimulating hormone per day conform normal stimulation protocol starting from cycle day 3, 4 or 5.   Once the dominant follicle(s) reach a mean diameter of 16-18 mm, hCG (5000IU or 250 mcg) will be applied and insemination will be scheduled 36-42 hours later. Patients will be followed for the time of one menstrual cycle."
        }, 
        "biospec_descr": {
            "textblock": "blood sample tested for FSH, E2 and AMH"
        }, 
        "biospec_retention": "Samples With DNA", 
        "brief_summary": {
            "textblock": "This large prospective multi-center cohort study aims to identify patient's characteristics\n      that significantly influence ovarian response to mild stimulation with a fixed dose of 75 IU\n      recombinant FSH."
        }, 
        "brief_title": "Predicting Ovarian Response in Artificial Insemination With Low Stimulation", 
        "completion_date": {
            "#text": "March 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Subfertility", 
        "condition_browse": {
            "mesh_term": "Infertility"
        }, 
        "detailed_description": {
            "textblock": "A multi-center, open-label, prospective cohorts study. Patients with a regular indication\n      for COH/IUI (controlled ovarian stimulation/ intra uterine insemination) will be asked to\n      participate. Patient's characteristics will be documented including age, weight, BMI,\n      smoking status, cycle day 2 3 or 4 FSH /Estradiol levels, antral follicle count, and AMH.\n      AMH and FSH/Estradiol will be determined centrally after completion of inclusion of all\n      patients in the study. All patients will receive a fixed 75 IU recFSH per day conform normal\n      stimulation protocol starting from cycle day 3, 4 or 5 after exclusion of ovarian cysts by\n      ultrasound. Ovarian response will be documented by ultrasound only. Once the dominant\n      follicle(s) reach a mean diameter of 16-18 mm, hCG (5000IU or 250 mcg) will be applied and\n      insemination will be scheduled 36-42 hours later. Cancellation criteria will be defined\n      according to the national guidelines provided by the NVOG (7)."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  couples with unexplained or mild male subfertility (1-3) and a spontaneous chance of\n             conception below 40% (Hunault score).\n\n          -  Unexplained subfertility including minimal to mild endometriosis (AFS grade 1 or 2)\n             is defined as the failure to conceive after at least one year of unprotected\n             intercourse whereas the standard fertility work-up was unable to detect any factors\n             that might influence fertility negatively.\n\n          -  semen analysis should be normal according to the WHO guidelines (8),\n\n          -  ovulation should be documented (by BBT charts, ovulation detection by ultrasound or\n             normal luteal progesterone values),\n\n          -  tubal patency should be confirmed (HSG, laparoscopy or fertiloscopy) and when a\n             postcoital test was performed a cervical factor should have been excluded.\n\n          -  Mild male subfertility is defined as abnormal semen parameters according to the WHO\n             (8) but an average total motile sperm account before processing of at least 10\n             million.\n\n        Exclusion Criteria:\n\n          -  Hunault score \u2265 40%\n\n          -  Endometriosis AFS grade 3 or 4\n\n          -  Contra-indications for the use of gonadotrophins (cysts larger than 2    cm, allergy\n             for gonadotrophins)\n\n          -  Total motile sperm count after sperm processing below 1 million\n\n          -  Women aged younger than eighteen years or older than 45 years.\n\n          -  Previous treatment with COH/IUI for treating current subfertility\n\n          -  Unable to speak or read the Dutch language"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "45 Years", 
            "minimum_age": "18 Years", 
            "sampling_method": "Probability Sample", 
            "study_pop": {
                "textblock": "Subfertile couples presenting at fertility clinics with an indication for IUI in\n        stimulated cycles"
            }
        }, 
        "enrollment": {
            "#text": "510", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "July 26, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01662180", 
            "org_study_id": "PRORAILS trial"
        }, 
        "intervention": {
            "arm_group_label": "Subfertile couples", 
            "description": "All patients will receive a fixed 75 IU rec follicle stimulating hormone per day subcutaneous injection stimulation protocol starting from cycle day 3, 4 or 5. The intervention done in this study is conform normal stimulation protocol and is not the target of this study.", 
            "intervention_name": "Follicle Stimulating Hormone", 
            "intervention_type": "Drug", 
            "other_name": [
                "Puregon [Merck Sharp & Dohme bv]", 
                "Gonal -F [Serono Benelux bv]"
            ]
        }, 
        "intervention_browse": {
            "mesh_term": [
                "Hormones", 
                "Follicle Stimulating Hormone"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": "subfertility, IUI, rec FSH, FSH, E2, AMH", 
        "lastchanged_date": "December 12, 2012", 
        "link": {
            "description": "PRORAILS website", 
            "url": "http://www.studies-obsgyn.nl/prorails"
        }, 
        "location": [
            {
                "contact": {
                    "email": "e.m.kaaijk@olvg.nl", 
                    "last_name": "Eugenie Kaaijk, dr.", 
                    "phone": "0031205993481"
                }, 
                "contact_backup": {
                    "email": "s.l.m.logtenberg@olvg.nl", 
                    "last_name": "Sabine Logtenberg", 
                    "phone": "003120-5999111"
                }, 
                "facility": {
                    "address": {
                        "city": "Amsterdam", 
                        "country": "Netherlands", 
                        "state": "Po 95500", 
                        "zip": "1090 HM"
                    }, 
                    "name": "OLVG"
                }, 
                "investigator": {
                    "last_name": "Eugenie Kaaijk, dr.", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "m.m.bloemendal@isala.nl", 
                    "last_name": "Maaike Bloemendal, Drs.", 
                    "phone": "0031384247506"
                }, 
                "contact_backup": {
                    "email": "h.j.m.hulsebos@isala.nl", 
                    "last_name": "Henriette Hulsebos", 
                    "phone": "0031384247783"
                }, 
                "facility": {
                    "address": {
                        "city": "Zwolle", 
                        "country": "Netherlands", 
                        "state": "PO Box 10400", 
                        "zip": "8000 GK"
                    }, 
                    "name": "Isala Klinieken"
                }, 
                "investigator": {
                    "last_name": "Ben Cohlen, dr.", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "minouche.v.rumste@catharinaziekenhuis.nl", 
                    "last_name": "Minouche van Rumste, dr.", 
                    "phone": "003140 239 71 00"
                }, 
                "contact_backup": {
                    "email": "milou.peters@catharinaziekenhuis.nl", 
                    "last_name": "Milou Peters", 
                    "phone": "00316-5102 8887"
                }, 
                "facility": {
                    "address": {
                        "city": "Eindhoven", 
                        "country": "Netherlands", 
                        "state": "PO box 1350", 
                        "zip": "5602 ZA"
                    }, 
                    "name": "Catharina Ziekenhuis"
                }, 
                "investigator": {
                    "last_name": "Minouche van Rumste, dr.", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "f.vanderveen@amc.uva.nl", 
                    "last_name": "Fulco van der Veen, prof. dr.", 
                    "phone": "003120 - 566 4287"
                }, 
                "contact_backup": {
                    "email": "t.s.devries@amc.uva.nl", 
                    "last_name": "Tessa de Vries", 
                    "phone": "00316 - 23799274"
                }, 
                "facility": {
                    "address": {
                        "city": "Amsterdam", 
                        "country": "Netherlands", 
                        "state": "PO box 22660", 
                        "zip": "1100 DD"
                    }, 
                    "name": "AMC"
                }, 
                "investigator": {
                    "last_name": "Fulco van der Veen, prof. dr.", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "cb.lambalk@vumc.nl", 
                    "last_name": "Cornelis Lambalk, prof. dr.", 
                    "phone": "0031204444444"
                }, 
                "contact_backup": {
                    "email": "m.devos-brouwer@vumc.nl", 
                    "last_name": "Angelique de Vos-Brouwer", 
                    "phone": "003120-4442180"
                }, 
                "facility": {
                    "address": {
                        "city": "Amsterdam", 
                        "country": "Netherlands", 
                        "state": "PO box 7057", 
                        "zip": "1007 MB"
                    }, 
                    "name": "VUMC"
                }, 
                "investigator": {
                    "last_name": "Cornelis Lambalk, prof. dr.", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "f.broekmans@umcutrecht.nl", 
                    "last_name": "Frank Broekmans, prof. dr.", 
                    "phone": "088-7551041"
                }, 
                "contact_backup": {
                    "email": "M.J.T.Kosterman@umcutrecht.nl", 
                    "last_name": "Marian Kosterman", 
                    "phone": "088-7555555"
                }, 
                "facility": {
                    "address": {
                        "city": "Utrecht", 
                        "country": "Netherlands", 
                        "state": "PO box 85500", 
                        "zip": "3508 GA"
                    }, 
                    "name": "UMC Utrecht"
                }, 
                "investigator": {
                    "last_name": "Frank Broekmans, prof. dr.", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "j.smeenk@elizabeth.nl", 
                    "last_name": "Jesper Smeenk, dr.", 
                    "phone": "0031013539 30 06"
                }, 
                "facility": {
                    "address": {
                        "city": "Tilburg", 
                        "country": "Netherlands", 
                        "state": "PO box 90151", 
                        "zip": "5000 LC"
                    }, 
                    "name": "st Elizabeth Gasthuis"
                }, 
                "investigator": {
                    "last_name": "Jesper Smeenk, dr.", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }
        ], 
        "location_countries": {
            "country": "Netherlands"
        }, 
        "number_of_groups": "1", 
        "official_title": "Predicting Ovarian Response in Artificial Insemination With Low Stimulation", 
        "overall_contact": {
            "email": "m.m.bloemendal@isala.nl", 
            "last_name": "Maaike M Bloemendal, Drs.", 
            "phone": "0031384247506"
        }, 
        "overall_contact_backup": {
            "email": "b.cohlen@isala.nl", 
            "last_name": "Ben Cohlen, Dr.", 
            "phone": "0031384247570"
        }, 
        "overall_official": {
            "affiliation": "Isala Klinieken", 
            "last_name": "Ben Cohlen, dr.", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Netherlands: Medical Ethics Review Committee (METC)", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "September 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "(defined by the number of dominant follicles >15mm) in IUI cycles stimulated with a fixed dose of 75 IU recFSH. All follicles > 11 mm will be documented", 
            "measure": "To assess the relationship between AMH serum levels and ovarian response", 
            "safety_issue": "No", 
            "time_frame": "one menstrual cycle, one month"
        }, 
        "reference": [
            {
                "PMID": "17943739", 
                "citation": "Bensdorp AJ, Cohlen BJ, Heineman MJ, Vandekerckhove P. Intra-uterine insemination for male subfertility. Cochrane Database Syst Rev. 2007 Oct 17;(4):CD000360. Review."
            }, 
            {
                "PMID": "17054143", 
                "citation": "Verhulst SM, Cohlen BJ, Hughes E, Te Velde E, Heineman MJ. Intra-uterine insemination for unexplained subfertility. Cochrane Database Syst Rev. 2006 Oct 18;(4):CD001838. Review."
            }, 
            {
                "PMID": "9207576", 
                "citation": "Tummon IS, Asher LJ, Martin JS, Tulandi T. Randomized controlled trial of superovulation and insemination for infertility associated with minimal or mild endometriosis. Fertil Steril. 1997 Jul;68(1):8-12."
            }, 
            {
                "PMID": "18983747", 
                "citation": "Freiesleben NL, Lossl K, Bogstad J, Bredkjaer HE, Toft B, Loft A, Bangsboll S, Pinborg A, Budtz-J\u00f8rgensen E, Andersen AN. Predictors of ovarian response in intrauterine insemination patients and development of a dosage nomogram. Reprod Biomed Online. 2008 Nov;17(5):632-41."
            }, 
            {
                "PMID": "19602518", 
                "citation": "la Cour Freiesleben N, Lossl K, Bogstad J, Bredkjaer HE, Toft B, Rosendahl M, Loft A, Bangsboll S, Pinborg A, Nyboe Andersen A. Individual versus standard dose of rFSH in a mild stimulation protocol for intrauterine insemination: a randomized study. Hum Reprod. 2009 Oct;24(10):2523-30. Epub 2009 Jul 14."
            }, 
            {
                "PMID": "20303323", 
                "citation": "Freiesleben Nl, Rosendahl M, Johannsen TH, L\u00f8ssl K, Loft A, Bangsb\u00f8ll S, Friis-Hansen L, Pinborg A, Andersen AN. Prospective investigation of serum anti-M\u00fcllerian hormone concentration in ovulatory intrauterine insemination patients: a preliminary study. Reprod Biomed Online. 2010 May;20(5):582-7. doi: 10.1016/j.rbmo.2010.02.007. Epub 2010 Feb 12."
            }, 
            {
                "PMID": "19934213", 
                "citation": "Cooper TG, Noonan E, von Eckardstein S, Auger J, Baker HW, Behre HM, Haugen TB, Kruger T, Wang C, Mbizvo MT, Vogelsong KM. World Health Organization reference values for human semen characteristics. Hum Reprod Update. 2010 May-Jun;16(3):231-45. Epub 2009 Nov 24. Review."
            }, 
            {
                "PMID": "19793843", 
                "citation": "La Marca A, Sighinolfi G, Radi D, Argento C, Baraldi E, Artenisio AC, Stabile G, Volpe A. Anti-Mullerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART). Hum Reprod Update. 2010 Mar-Apr;16(2):113-30. Epub 2009 Sep 30. Review."
            }, 
            {
                "PMID": "22238112", 
                "citation": "Nelson SM, Anderson RA, Broekmans FJ, Raine-Fenning N, Fleming R, La Marca A. Anti-M\u00fcllerian hormone: clairvoyance or crystal clear? Hum Reprod. 2012 Mar;27(3):631-6. Epub 2012 Jan 11."
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01662180"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Isala Klinieken", 
            "investigator_full_name": "M. Bloemendal", 
            "investigator_title": "drs.", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "(defined by the number of dominant follicles >15mm) in IUI cycles stimulated with a fixed dose of 75 IU recFSH.", 
                "measure": "To assess the relationship between age, weight, BMI, smoking, AFC, FSH/E2 on CD3 and ovarian response", 
                "safety_issue": "No", 
                "time_frame": "one menstrual cycle, one month"
            }, 
            {
                "description": "From start of the menstrual cycle until a positive heartbeat registered at 12 weeks of gestation.", 
                "measure": "Pregnancy rate per started cycle.", 
                "safety_issue": "No", 
                "time_frame": "three months"
            }, 
            {
                "description": "From start of the menstrual cycle until  positive heartbeats registered at 12 weeks of gestation.", 
                "measure": "Multiple pregnancy rate per started cycle.", 
                "safety_issue": "No", 
                "time_frame": "three months"
            }, 
            {
                "description": "miscarriage up to 16 weeks of gestation", 
                "measure": "Miscarriage rate per started cycle.", 
                "safety_issue": "No", 
                "time_frame": "five months"
            }, 
            {
                "measure": "Cancellation rate per stimulated cycle", 
                "safety_issue": "No", 
                "time_frame": "one menstrual cycle, one month"
            }
        ], 
        "source": "Isala Klinieken", 
        "sponsors": {
            "collaborator": {
                "agency": "Merck Serono International SA", 
                "agency_class": "Industry"
            }, 
            "lead_sponsor": {
                "agency": "Isala Klinieken", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "December 2012", 
        "study_design": "Observational Model: Cohort, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "December 2012"
    }
}